MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    DCM extract of Scutellaria Pinnatifida modulate alpha-synuclein fibrillation and protects dopaminergic SH-SY5Y cells against rotenone

    S. Parsafar, D. Morshedi, M. Mohammadi (Tehran, Islamic Republic of Iran)

    Objective: The aim of this study is to evaluate the effect of Dichloromethane extract (DCMex) of Scutellaria Pinnatifida (S) on of alpha-synuclein (ASN) and effect…
  • 2019 International Congress

    Identifying healthy Parkin mutation carriers based on sensor-based posturography and gait analysis

    J. Prasuhn, M. Borsche, A. Hicks, M. Gögele, C. Egger, C. Kritzinger, L. Langlott, M. Kasten, C. Klein, P. Pramstaller, N. Brüggemann (Lübeck, Germany)

    Objective: To discriminate healthy Parkin mutation carriers from healthy non-mutation carriers using sensor-based motion analysis. Background: Identifying endophenotypes for PD is crucial for testing potential…
  • 2019 International Congress

    Parkinsonism and rapidly progressive dementia secondary to free-living ameba

    M. Rubio Hernandez, I. Rodriguez Leyva, M. Tello Zavala, A. Ortiz Alvarez, C. Gallegos Rios (San Luis Potosi, Mexico)

    Objective: Present an original case description of a patient with amebic meningoencephalitis. Background: Parkinsonism could be caused by degenerative disorders, brain injuries, drugs, toxins, and…
  • 2019 International Congress

    Early diagnosis of progressive supranuclear palsy using quantitative MRI analysis of brain structure

    K. Seo, T. Yamamoto, H. Kawasaki, T. Hukuoka, Y. Nakazato, K. Takahashi, I. Matunari, H. Matuda, N. Tamura, N. Araki (Saitama, Japan)

    Objective: We examined whetherquantitative MRI analysis of brain structure was useful for early diagnosis of PSP. Background: Quantitative analysis of brain structure by means of…
  • 2019 International Congress

    Serological analysis of circulating Alpha Synuclein protein levels by Surface Plasmon Resonance (SPR) In Parkinson’s disease

    A. Singh, T. Bajaj, A. Dey, S. Dey (New Delhi, India)

    Objective: α-synuclein (α-Syn) is a presynaptic protein whose overexpression or misfolding contributes to the pathophysiology of Parkinson’s disease (PD). This study aims to estimate the…
  • 2019 International Congress

    Drooling in Parkinson’s Disease: A [123I]FP-CIT SPECT study

    V. Suarez Contreras, Y. Tayyabah, S. Caminiti, M. Politis (London, United Kingdom)

    Objective: Evaluate the association between drooling and striatal dopamine terminals. Test the assumption that drooling correlates with disease progression in de novo Parkinson’s disease (PD)…
  • 2019 International Congress

    PSP-like syndrome after aortic in adults (Mokri syndrome)

    S. Tisel, J. Ahlskog, J. Matsumoto, J. Duffy, K. Josephs (Minneapolis, MN, USA)

    Objective: Characterize the syndrome resembling progressive supranuclear palsy (PSP) following aortic surgery. Background: Mokri, et al. reported a PSP-like syndrome seemingly triggered by aortic surgery…
  • 2019 International Congress

    Hoover’s Sign in Parkinson’s Disease

    A. Vasilenko, M. Karpova (Chelyabinsk, Russian Federation)

    Objective: To study applicability of Hoover's sign to diagnostics of functional component in PD. Background: It has been reported that Parkinson’s Disease (PD) patients have…
  • 2019 International Congress

    Osteopathic Manipulative Medicine to Improve Balance and Quality of Life in Parkinson Disease

    S. Yao, J. Docherty, J. Mancini, A. Leder, J. Difrancisco-Donoghue (Old Westbury, NY, USA)

    Objective: To examine the effects of Osteopathic Manipulative Medicine (OMM) using a pre-defined protocol for 6 weeks and compare that to a 6-week counseling protocol…
  • 2019 International Congress

    Ambroxol treatment of primary macrophages derived from patients with GBA-associated Parkinson’s disease

    A. Kopytova, M. Nikolaev, K. Senkevich, G. Baydakova, I. Miliukhina, E. Zakharova, S. Pchelina (Gatchina, Russian Federation)

    Objective: The aim was to evaluate the effectiveness of the restoration of GCase activity in macrophages from GBA-PD patients using pharmacological chaperone ambroxol. Background: Mutations…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley